How the shift happens
This is the shift the rest of the overview builds around.
What actually happens is that a larger-than-usual, synchronized group of follicles shifts from the growth (anagen) phase into the resting (telogen) phase all at once — a shift researchers link to general trigger categories like inflammation, hormonal change, physical or emotional stress, nutritional deficiency, poor sleep, or certain medications.
The normal hair cycle includes anagen, catagen, telogen, and exogen phases, with telogen (the resting phase) normally holding around 9% of scalp follicles at any given time.
Why the distinction matters
That distinction is where a practitioner's judgment actually comes in.
Telling diffuse, temporary shedding apart from progressive, patterned hair loss matters for exactly this reason: reviews of cases labeled ‘chronic’ telogen effluvium have found that many likely represent early patterned hair loss or an ongoing trigger that hasn't been identified yet — and biopsy studies in these cases have shown normal ratios of thick-to-thin hairs, unlike the pattern typically seen in progressive hair loss.
Illness episodes on a large scale, such as a global pandemic, show how a systemic trigger can be followed by a rise in reported telogen effluvium, though the exact biological mechanism connecting the two still isn't clear.
What this page can — and cannot — tell you
Scope: This overview describes telogen effluvium as a pattern of temporary, diffuse shedding related to the normal hair cycle, general trigger categories, and why distinguishing it from progressive/patterned hair loss matters for observation-based judgment. It does not address diagnosis of any individual's underlying cause, laboratory or serologic testing, trichoscopy or biopsy protocols, medication dosing or prescribing (including oral/topical minoxidil or GLP-1 receptor agonists), treatment efficacy or comparisons, or androgenetic alopecia, alopecia areata, or traction alopecia as their own conditions. A vitamin-D-specific (and bundled serum-ferritin) biomarker association claim for telogen effluvium is also omitted because the evidence on its statistical significance is genuinely unresolved between sources and is non-core to this page's purpose.
Epidemiological estimates of telogen effluvium prevalence come mostly from outpatient populations and could not reliably separate acute from chronic presentations.
The hair-cycle description synthesized here draws on a narrative clinical review rather than a systematic review or formal guideline.
There is no consensual definition of chronic/persistent telogen effluvium across the literature, no study has documented exclusion of all possible alternative causes of shedding, and most available evidence is cross-sectional or case-series based with little longitudinal follow-up.
Key takeaways
-
01
Telogen effluvium is a transient, nonscarring, diffuse increase in hair shedding that follows a precipitating trigger.
-
02
Distinguishing diffuse, temporary shedding from progressive or patterned hair loss matters clinically: reviews of cases labeled 'chronic telogen effluvium' have found that many likely represent early patterned hair loss or unresolved secondary triggers, and biopsy series in these cases showed normal ratios of thick-to-thin hairs, rather than the pattern typically associated with progressive hair-loss conditions.
-
03
The normal hair cycle includes anagen, catagen, telogen, and exogen phases, with telogen (the resting phase) normally holding around 9% of scalp follicles at any given time.
Sources & references
The cleared source set supporting this page's evidence review.
- Nicole Natarelli, Nimrit Gahoonia, Raja K. Sivamani. Integrative and Mechanistic Approach to the Hair Growth Cycle and Hair Loss
- Adam Daunton, Matthew Harries, Rodney Sinclair, Ralf Paus, Antonella Tosti, Andrew Messenger. Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review
- Jae Joon Jeon, You Hyun Kim, HyunJun Kang, Min Chul Ha, Seung-Won Jung, Hyunsoo Son, Myung Ha Kim, Won-Soo Lee, Solam Lee. Global epidemiology of telogen effluvium after the COVID-19 pandemic: A systematic review and modeling study
- Ian Landells, Aditya K. Gupta, Julio C. Jasso Olivares, Eunice Y. Chow, Thusanth Thuraisingam, Renita Ahluwalia, Geeta Yadav, Michelle Pratt, Noemie Vezina, Elias Raad, Jayden Owen, Nour R. Dayeh. A Canadian Algorithm on the Management of Telogen Effluvium